Associate Director, Real World Data Statistics

BENGALURU (IN)HYBRIDPOSTED: 9/29/2026
PHARMAFull time
HIRING ORGANIZATIONASTRAZENECAPharmaceuticals / Biopharmaceuticals / Healthcare
AstraZeneca

ROLE OVERVIEW

Alexion, AstraZeneca's rare disease unit, is expanding its epidemiology and real-world evidence capability in Bangalore with an Associate Director I/II, Real World Data Statistics. This individual-contributor leadership role sits at the intersection of advanced biostatistics and regulatory science, converting disease registry, natural history, EMR and claims data into evidence robust enough to withstand FDA, EMA and other health authority scrutiny. The position matters because rare disease programmes depend on external data to characterise small, dispersed patient populations, support label expansions and satisfy post-market commitments. For an experienced statistician it offers unusual scope: methodological innovation in missingness, linkage and confounding control, direct exposure to health authority interactions, and mentorship of a growing RWD statistics function within a biotech-paced, patient-centred environment backed by AstraZeneca's global scale.

ROLE DEFINITION & RESPONSIBILITIES

  • •Lead statistical strategy and analysis plans for registry-based evidence supporting rare disease regulatory submissions and post-market commitments.
  • •Design, program and validate survival analyses, causal inference, propensity score matching and longitudinal models on registry, EMR and claims data.
  • •Develop regulatory-quality deliverables — statistical analysis plans, tables/figures/listings and briefing documents — aligned to the FDA RWE Framework and EMA registry guidance.
  • •Innovate methodologies for missingness, data linkage, confounding control and outcome validation, sharing findings internally and through publications.
  • •Partner with clinical, epidemiology, regulatory and registry operations teams, and represent Alexion at advisory boards and health authority meetings.
  • •Ensure reproducibility, audit readiness and transparent reporting across all statistical deliverables.
  • •Translate complex analyses into clear narratives for executive leadership and submission dossiers.
  • •Mentor RWD statisticians through code review, knowledge-sharing and career development guidance.

QUALIFICATIONS & REQUIREMENTS

REQUIRED QUALIFICATIONS

  • PhD in statistics, biostatistics or epidemiology with a minimum of 7 years of relevant industry experience.
  • Or a Master's degree with a minimum of 10 years of relevant pharmaceutical, CRO or observational research experience.
  • Proven track record of generating real-world evidence for rare disease or similarly small patient populations.
  • Demonstrated leadership of regulatory submissions built on registry-based analyses.
  • Experience presenting analyses in health authority or scientific advisory settings.
  • Expert proficiency in R and/or SAS, with working knowledge of SQL or Python for data engineering and validation.
  • Strong publication or conference record in pharmacoepidemiology or applied RWE methodology.

PREFERRED QUALIFICATIONS

  • •Rare disease and orphan drug regulatory experience
  • •Health authority briefing document authorship
  • •CDISC and regulatory submission data standards
  • •Statistical capability building and mentorship
  • •Pharmacoepidemiology publication leadership

REQUIRED VERIFIED SKILLS

Real-World Evidence (RWE) Study Design
Registry and Observational Cohort Analytics
Survival Analysis and Longitudinal Modelling
Propensity Score Matching and Causal Inference
FDA Real-World Evidence Framework
EMA Registry-Based Study Guidance
Statistical Analysis Plan (SAP) Development
R and SAS Programming
SQL and Python for Data Validation
Missing Data and Data Linkage Strategies

COMPENSATION & REWARDS

Salary: Competitive / Disclosed upon candidate shortlisting

ORGANIZATION CONTEXT & CULTURE

AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialisation of prescription medicines. The company operates in various therapeutic areas, including Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is committed to pushing the boundaries of science to deliver life-changing medicines and improve patient outcomes worldwide.

TEAM SIZE: 89,000+ employees
INDUSTRY: Pharmaceuticals / Biopharmaceuticals / Healthcare

EXPECTED CAREER ROADMAP

From Associate Director I/II, the natural progression is to Director, Biostatistics or Head of Real World Evidence within Alexion or AstraZeneca's wider Biometrics function, with lateral scope into regulatory affairs strategy, epidemiology or market access and HEOR leadership. Two to five years in this seat builds a portfolio of health-authority-reviewed registry analyses that is highly portable: comparable roles exist at global pharma R&D sites, CROs, and consultancies specialising in RWE and pharmacoepidemiology, as well as Indian biopharma companies building late-phase evidence functions. The mentorship and methodological innovation components also position strong performers for academic adjunct appointments and industry advisory board invitations.

APPLICATION ADVISORY

Lead your CV with two or three registry or observational studies you took through a regulatory milestone, naming the data source, methodology and health authority outcome. Interviewers will probe survival analysis choices, propensity score implementation, missing-data handling and how you defended assumptions to the FDA or EMA, so prepare concrete examples with numbers. Refresh R or SAS code fluency, be ready to discuss RWE framework compliance, and rehearse a concise narrative that translates a complex analysis for a non-statistical executive audience.

READY TO SUBMIT?

Verify your capability profile and matching credentials before submitting direct applications.